MedPath

Fludarabine Phosphate

These highlights do not include all the information needed to use FLUDARABINE PHOSPHATE safely and effectively. See full prescribing information for .  Injection, for intravenous use only Initial U.S. Approval: 1991

Approved
Approval ID

0170c0f4-d502-4f8f-bdbf-6439f3ed33fb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 31, 2023

Manufacturers
FDA

Lannett Company, Inc.

DUNS: 002277481

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fludarabine Phosphate

PRODUCT DETAILS

NDC Product Code0527-1242
Application NumberANDA090724
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateSeptember 13, 2022
Generic NameFludarabine Phosphate

INGREDIENTS (4)

FLUDARABINE PHOSPHATEActive
Quantity: 25 mg in 1 mL
Code: 1X9VK9O1SC
Classification: ACTIB
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fludarabine Phosphate - FDA Drug Approval Details